onlyuse ersonal23 FEBRUARY 2022
1H22 RESULTS PRESENTATION
DISCLAIMER
The following provisions apply to this presentation. Please consider its contents carefully.
Currency of information
The information contained in this presentation is current as at the date of this presentation or such earlier date as specified in this presentation.
Summary information
only | |
The information in this presentation is of a general nature only. It does not purport to be complete. | |
Not investment advice | |
The information contained in this presentation is not investment or financial product advice or any recommendation to acquire securities in McPherson's Limited (ASX: MCP). This presentation has been | |
prepared without taking into account your investment objectives, financial situation or particular needs. | |
Company information | |
MCP's historical information in this presentation is, or is based on, information that has been released to ASX. This presentation should be read in conjunction with MCP's other periodic and continuous | |
disclosure information lodged with ASX, which are available at www.asx.com.au. | |
Third party information | |
use | |
C rtain market and industry data used in connection with this presentation may have been obtained from research, surveys or studies conducted by third parties, including industry or general publications. | |
Neither MCP nor any of its related bodies corporate, directors, employees, agents or advisers have independently verified such market or industry data. | |
Hi torical information | |
Past performance information in this presentation is given for illustrative purposes only and should not be relied upon as, and is not, an indication of future performance. | |
Forward looking information | |
ersonal | |
This presentation contains certain forward-looking statements that involve risks and uncertainties. MCP can give no assurance that these expectations will prove to be correct. You are cautioned not to | |
pl ce undue reliance on any forward-looking statements. Actual results may differ materially from those anticipated in these forward-looking statements due to many important factors, risks and | |
uncert inties including, without limitation, risks associated with future capital needs, general economic uncertainty and other risks detailed from time to time in MCP's announcements to ASX. MCP does | |
not undertake any obligation to release publicly any revisions to any "forward-looking statement" to reflect events or circumstances after the date of this presentation, except as may be required under | |
applicable laws. | |
Disclaimer | |
No representation or warranty, whether express or implied, is made by any person as to the fairness, accuracy, completeness or correctness of the information, opinions and conclusions contained in this | |
presentation. You should carry out your own investigations and analysis of MCP and verify the accuracy, reliability and completeness of the information contained in this presentation. | |
Neither MCP nor any of its related bodies corporate, directors, employees, agents and advisers accept any responsibility for any loss arising from anyone acting or refraining from acting in reliance on the | |
contents of this presentation. | |
1h22 r sults r lease | 2 |
only 1H22 RESULTS
usePRESENTATION AGENDA
1. Overview
2. Financial Performance ersonal3. Division Highlights
4. Update on Operational Review
5. Outlook
1h22 r sults r lease
OVERVIEW
ersonal use only
$108.8M | 11% |
TOTAL SALES | ORGANIC GROWTH - |
REVENUE | DOMESTIC OWNED |
1H21: $101.7M | BRANDS |
$7.2M | 48% |
UNDERLYING* EBIT | CASH CONVERSION |
1H21: $7.5M | 1H21: 67% |
7.3% | 3.0 CPS |
GEARING | INTERIM DIVIDEND |
NET DEBT: $8.8M | FULLY FRANKED |
1H22 SUMMARY:
- Organic domestic growth with owned brand sales up 11%, driven by Manicare, Lady Jayne and Swisspers, despite COVID-19related challenges
- Underlying* PBT of $6.7m and statutory LBT of ($3.0)m in line with stated guidance
- Strong balance sheet with low net debt and gearing
- Finalised $9.4m provision for Dr. LeWinn's Inventory
- Broader channel and portfolio strategy to be initiated for Dr. LeWinn's in China
- Continued progress on initiatives resulting from operational review
- Unchanged FY22 guidance, subject to no unforeseen circumstances
1h22 r sults r lease
* Excluding material non-recurring items. Refer to the reconciliation of underlying to statutory results contained in the appendix of the ASX Results Release dated 23 February 2022. | 4 |
HEALTH, WELLNESS & BEAUTY - A $17BN MARKET
MCP CORE BRANDS OUTPERFORMING PHARMACY AND GROCERY AND CHANNEL GROWTH
use only | |||||||
STRONG DEMAND FOR OUR BRANDS | |||||||
#1 Australian | Leading Natural | #1 Beauty Tools | #1 Hair Tools & | #1 Foil, Bake, Garbage | #1 Cotton | ||
Cosm ceutical Brand | Haircare in Pharmacy | & Accessories | Accessories | & Freezer Bags | |||
ersonalSourc : Data sourced from IRI MarketEdge based on data definitions provided by McPherson's Consumer Products. Australian Pharmacy & Grocery Weighted Market. Beauty Accessories , Hair Accessories Category MAT 05//12/21; Cotton, Facial Skincare, Haircare, BWF category MAT 05/12/21 | 5 | ||||||
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
McPherson's Limited published this content on 22 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 February 2022 23:38:05 UTC.